Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
40.25 CHF | -0.86% | +0.25% | -5.85% |
Apr. 27 | Tranche Update on BB Biotech AG?s Equity Buyback Plan announced on April 12, 2022. | CI |
Apr. 26 | Switzerland's BB Biotech Swings to Q1 Profit; Operating Income Jumps | MT |
Sales 2024 * | 190M 213M | Sales 2025 * | 101M 113M | Capitalization | 2.21B 2.48B |
---|---|---|---|---|---|
Net income 2024 * | 152M 171M | Net income 2025 * | 72M 80.85M | EV / Sales 2024 * | 13.2 x |
Net Debt 2024 * | 291M 327M | Net Debt 2025 * | 324M 364M | EV / Sales 2025 * | 25.2 x |
P/E ratio 2024 * |
14.5
x | P/E ratio 2025 * |
13.5
x | Employees | 10 |
Yield 2024 * |
5.84% | Yield 2025 * |
5.96% | Free-Float | 97.24% |
1 day | -0.86% | ||
1 week | +0.25% | ||
Current month | +0.75% | ||
1 month | -4.62% | ||
3 months | -12.31% | ||
6 months | +7.19% | ||
Current year | -5.85% |
Managers | Title | Age | Since |
---|---|---|---|
Daniel Koller
CIO | Chief Investment Officer | 54 | 03-12-31 |
- | - | ||
- | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Clive Meanwell
BRD | Director/Board Member | 67 | 03-12-31 |
Director/Board Member | 63 | 19-12-31 | |
Chairman | 63 | 19-03-20 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-04 | 40.25 | -0.86% | 77,476 |
24-06-03 | 40.6 | +1.63% | 97,641 |
24-05-31 | 39.95 | +0.63% | 35,810 |
24-05-30 | 39.7 | +0.13% | 62,482 |
24-05-29 | 39.65 | -1.25% | 79,034 |
Delayed Quote Swiss Exchange, June 04, 2024 at 11:31 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-5.85% | 2.49B | |
+46.19% | 56.65B | |
-6.14% | 39.44B | |
+39.19% | 39.03B | |
-6.65% | 26.86B | |
+12.33% | 26.75B | |
-21.78% | 19.03B | |
-0.35% | 12.28B | |
+24.18% | 12.26B | |
+28.38% | 12.04B |
- Stock Market
- Equities
- BION Stock